Prosecution Insights
Last updated: April 19, 2026

Arcturus Therapeutics, Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18614077 LIPID NANOPARTICLES ENCAPSULATION OF LARGE RNA SASAN, ARADHANA 1615 Non-Final OA Mar 22, 2024
18001571 UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES VANHORN, ABIGAIL LOUISE 1636 Non-Final OA Dec 12, 2022
18052505 LIPID FORMULATIONS CONTAINING NUCLEIC ACIDS AND METHODS OF TREATMENT FOR CYSTIC FIBROSIS WARD, PAUL V 1622 Non-Final OA Nov 03, 2022
17737690 IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY KELLY-O'NEILL, YOLANDA LYNNETTE 1692 Final Rejection May 05, 2022
17737884 LIPID COMPOSITIONS COMPRISING PEPTIDE-LIPID CONJUGATES CRUM, MARY ABOU NADER 1657 Final Rejection May 05, 2022

Managing Arcturus Therapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month